An active targeting probe was reported by Yari et al. [36], who designed the P3 lipopolymer that could be used to functionalize liposomes for targeted delivery of therapeutics/diagnostics to PSMA-positive PCa cells. The gene discussed is FOLH1; the disease is posterior cortical atrophy.